Adaptive Trial Designs for Assessing Predictiveness of a Biomarker in Early Phase Drug Development
An adaptive design is proposed to improve power for detecting a predictive effect when sample sizes are small, and addresses key methodological challenges, including interim decision rules, determining the magnitude and allocation of post‐interim sample size increases, controlling the Type I error rate, and achieving m...